YIH
GMAB icon

Y-Intercept (HK)’s Genmab GMAB Stock Holding History

Y-Intercept (HK)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,668
Closed -$1.2M – 1887
2026
Q1 		$1.2M Buy
+44,668
New +$1.34M 0.02% 948
2025
Q3 		– Sell
-29,329
Closed -$606K – 1739
2025
Q2 		$606K Sell
29,329
-3,147
-10% -$64.6K 0.01% 1139
2025
Q1 		$636K Sell
32,476
-41,220
-56% -$865K 0.04% 598
2024
Q4 		$1.54M Buy
73,696
+58,048
+371% +$1.28M 0.1% 278
2024
Q3 		$381K Buy
15,648
+136
+0.9% +$3.64K 0.02% 911
2024
Q2 		$390K Sell
15,512
-3,164
-17% -$89.7K 0.02% 921
2024
Q1 		$559K Buy
+18,676
New +$549K 0.04% 656
2023
Q4 		– Sell
-10,629
Closed -$375K – 1390
2023
Q3 		$375K Buy
+10,629
New +$405K 0.04% 672
2023
Q2 		– Sell
-15,314
Closed -$578K – 1436
2023
Q1 		$578K Sell
15,314
-330
-2% -$12.7K 0.07% 451
2022
Q4 		$663K Buy
+15,644
New +$645K 0.1% 330
2021
Q3 		– Sell
-7,722
Closed -$315K – 746
2021
Q2 		$315K Sell
7,722
-3,178
-29% -$123K 0.08% 393
2021
Q1 		$346K Buy
+10,900
New +$410K 0.09% 352

Other funds holding GMAB

PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Y-Intercept (HK)'s GMAB Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Genmab (GMAB) in Q2 2026, closing a stake of 44,668 shares — an estimated $1.2M sold.

Y-Intercept (HK) first reported a position in GMAB in Q1 2021 and held it in 12 quarters. The position peaked at $1.54M in Q4 2024. 43 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 44,668 Genmab shares in Q2 2026, an estimated $1.2M.
  • Y-Intercept (HK) first reported a position in Genmab in Q1 2021 and held it in 12 quarters.
  • Y-Intercept (HK)'s Genmab position peaked at $1.54M in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.